ArticleReumatologia2026
Pleuropericardial effusion as a first presentation of systemic lupus erythematosus.
Article in Reumatologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus is a multisystem autoimmune disease with varied manifestations involving pulmonary features of pleuritis and pericarditis. These complications may be difficult to diagnose in early stages, as they mimic infectious symptoms. The paper sheds light on diagnostic and treatment challenges associated with lupus pleuropericardial effusions. Glucocorticosteroids (GCs) are usually the first-line treatment, but some patients do not respond to this therapy and require escalation to immunosuppressants or biologics. This is review based on studies published in peer-reviewed journals within past 20 years. The case of a patient with pleural effusion included in the article, in whom the diagnosis of SLE was made through the diagnosis of infection, as well as the cases from the available literature presented in the discussion, well illustrate the problem of symptoms that are part of the picture of SLE, but are non-specific and require differential diagnosis. Early diagnosis and treatment with immunosuppressive, immunemodulating drugs and biologics may lead to better outcomes; further research is needed to explore therapeutic options in difficult cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.